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ARTICLE
Specific Sequence Variations within the 4q35 Region Are
Associated with Facioscapulohumeral Muscular Dystrophy
Richard J. L. F. Lemmers, Marie¨lle Wohlgemuth, Kristiaan J. van der Gaag, Patrick J. van der Vliet,
Corrie M. M. van Teijlingen, Peter de Knijff, George W. Padberg, Rune R. Frants,
and Silve`re M. van der Maarel
Autosomal dominant facioscapulohumeral muscular dystrophy (FSHD) is mainly characterized by progressive wasting
and weakness of the facial, shoulder, and upper-arm muscles. FSHD is caused by contraction of the macrosatellite repeat
D4Z4 on chromosome 4q35. The D4Z4 repeat is very polymorphic in length, and D4Z4 rearrangements occur almost
exclusively via intrachromosomal gene conversions. Several disease mechanisms have been proposed, but none of these
models can comprehensively explain FSHD, because repeat contraction alone is not sufficient to cause disease. Almost-
identical D4Z4-repeat arrays have been identified on chromosome 10q26 and on two equally common chromosome 4
variants, 4qA and 4qB. Yet only repeat contractions of D4Z4 on chromosome 4qA cause FSHD; contractions on the other
chromosomes are nonpathogenic. We hypothesized that allele-specific sequence differences among 4qA, 4qB, and 10q
alleles underlie the 4qA specificity of FSHD. Sequence variations between these alleles have been described before, but
the extent and significance of these variations proximal to, within, and distal to D4Z4 have not been studied in detail.
We examined additional sequence variations in the FSHD locus, including a relatively stable simple sequence-length
polymorphism proximal to D4Z4, a single-nucleotide polymorphism (SNP) within D4Z4, and the A/B variation distal to
D4Z4. On the basis of these polymorphisms, we demonstrate that the subtelomeric domain of chromosome 4q can be
subdivided into nine distinct haplotypes, of which three carry the distal 4qA variation. Interestingly, we show that repeat
contractions in two of the nine haplotypes, one of which is a 4qA haplotype, are not associated with FSHD. We also
show that each of these haplotypes has its unique sequence signature, and we propose that specific SNPs in the disease
haplotype are essential for the development of FSHD.
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Facioscapulohumeral muscular dystrophy (FSHD [MIM
158900]) is the third-most-common myopathy with an
autosomal dominant pattern of inheritance. The disease
is mainly characterized by progressive wasting and weak-
ness of the facial, shoulder, and upper-arm muscles. FSHD
displays wide clinical variability, ranging from asymptom-
atic individuals with minimal clinical signs apparent only
on careful examination to patients who use wheelchairs.1
FSHD is caused by a contraction of the macrosatellite
repeat D4Z4 in the subtelomeric region of chromosome
4q35.2 The D4Z4 repeat array, which consists of single
repeat units of 3.3 kb, is very polymorphic in length
and is highly recombinogenic.3 Control individuals carry
D4Z4 repeats with 11–100 units, whereas the majority
of patients have a D4Z4-repeat size of 1–10 units on
one of their chromosomes 4. In 10%–30% of the cases,
FSHD is caused by a de novo contraction of the D4Z4
repeat. Intrachromosomal gene conversions underlie these
rearrangements.4
Detailed sequence analysis of the D4Z4 unit revealed
the presence of a putative ORF in addition to repetitive
sequences often found in heterochromatic domains of the
human genome.5,6 This intronless ORF, named “DUX4,”
encodes a 424-aa protein with two predicted homeobox
sequences.7 With consideration of the gradual spread in
muscle weakness and the crucial role of homeobox pro-
teins in body patterning during early development, DUX4
is considered a strong candidate for FSHD. However, con-
sistent evidence of expression emanating from D4Z4 is
lacking.7–9
Therefore, other models were proposed in which D4Z4
plays an indirect role in FSHD pathogenesis.10–13 All these
models predict a change in chromatin structure on D4Z4
contraction. Several observations corroborate these mod-
els: a protein repressor complex has been identified that
binds D4Z4 and suppresses the expression of genes in close
vicinity of the repeat.10 Moreover, D4Z4 is significantly
hypomethylated in FSHD alleles.13 Unfortunately, none of
these models can comprehensively explain FSHD, because
certain conditions, in addition to repeat contraction, need
to be met for disease to occur.
First, the D4Z4 contraction needs to occur on chro-
mosome 4q, since a very homologous and equally poly-
morphic D4Z4 repeat is located on chromosome 10q26,
but FSHD-sized D4Z4 repeats on 10q have never been as-
sociated with disease.14,15 Sequence analysis showed that
the 10q26 repeat is ∼98% identical to the 4q35 repeat, and
the regions extending 40 kb proximal to D4Z4 and at least
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10 kb distal to D4Z4 are highly homologous.16 Specific
sequence differences assist the molecular diagnosis of
FSHD by discriminating between repeats from both chro-
mosomes through the presence of chromosome-specific
restriction-recognition sites within the repeat units: BlnI
for 10q-derived repeat units and XapI for 4q-derived repeat
units.15,17
Second, the contraction needs to occur on a specific
variant of 4qter. Two subtelomeric variations distal to
D4Z4 were identified on chromosome 4, with alleles 4qA
and 4qB.16 The most prominent difference between 4qA
and 4qB alleles is the presence of a 260-bp sequence
(pLAM) followed by a 6.2-kb b-satellite repeat directly dis-
tal to D4Z4 on 4qA. Both variants are almost equally com-
mon in the control population. However, we have shown
that FSHD alleles are exclusively associated with the 4qA
variant.18
We hypothesized that allele-specific sequence differ-
ences are accumulating between 4qA and 4qB alleles be-
cause of a lack of allelic exchanges between 4qA and 4qB
and that some of these differences underlie the 4qA spec-
ificity of FSHD. A first indication that 4qA and 4qB sub-
telomeres evolve relatively independently came from the
observation that the distal A/B variation on 4qter was in
linkage disequilibrium (LD) with a G/C SNP within the
most proximal D4Z4 unit (hereafter designated as the
“D4Z4 SNP”).4 We showed the presence of the C variant,
which leads to an extra PvuII restriction site in D4Z4, in
29% of the 4qB alleles, whereas this restriction site was
almost absent in the 4qA alleles. This observation moti-
vated us to analyze the allelic variation of the D4Z4 region
on chromosomes 4 and 10 in more detail.
For this study, we used four polymorphisms in 4qter:
the repeat-size variation of D4Z4, the D4Z4 SNP, the dis-
tal A/B variation, and a relatively stable simple sequence-
length polymorphism (SSLP) located 3.5 kb proximal to
D4Z4. We confirmed the LD between the region proximal
and distal to D4Z4. On the basis of specific sequence var-
iations within and close to D4Z4, the subtelomeric region
of chromosome 4q can be subdivided into at least nine
haplotypes. Most importantly, we show that D4Z4 con-
tractions in one of the three 4qA haplotypes are not as-
sociated with FSHD.
Subjects and Methods
Control Individuals and Patients with FSHD
The polymorphic markers were determined in genomic DNA
from 222 unrelated healthy individuals and 86 independent in-
dividuals with sporadic and familial FSHD. All control and patient
DNA samples tested were randomly chosen from our collection
of 11,000 individuals. Blood from all individuals was collected
after informed consent was obtained.
Somatic Cell Hybrids and DNA Clones
The chromosome 4qA sources were the monochromosomal
rodent somatic cell hybrids HHW1494 and SU10 (gift from S.
Winokur, Irvine, CA) and phage clones l42, l68, and l260201.3
All these sources represent FSHD alleles. As chromosome 4qB
sources, we used the monochromosomal rodent somatic cell hy-
brids GM11687 (Coriell Institute for Medical Research, Camden,
NJ), 4L 10 (gift from E. Stanbridge, Irvine, CA), and HHW416 (gift
from M. Altherr, Los Alamos, NM). Chromosome 10qA sources
were cosmid C853 and the monochromosomal rodent somatic
cell hybrids 726 8a (U.K. Human Genome Mapping Project Re-
source Center) and GM11688 (Coriell Cell Repositories).
FSHD-Affected Families Rf10 and Rf204
Families Rf10 and Rf204 were ascertained via one of the Dutch
Neuromuscular Centers. In Rf10, four affected members who all
carry a 33-kb FSHD allele (4qA161; see the “Results” section) were
identified. In addition, a healthy spouse (II-9) who carried a dif-
ferent 33-kb allele (4qA166) was identified. Also, his brother (II-
11) carried this FSHD-sized 4qA166 allele and was not affected.
Family Rf204 has been described before (as “family A”)19 and
includes five patients with FSHD who carry a 17-kb FSHD allele
(4qA161). In this family, a second FSHD-sized allele of 24 kb
(4qA166) was found in an unaffected sister (II-11). Further anal-
ysis of this family revealed five unaffected children of the oldest,
deceased brother (II-1), who carried the same 24-kb allele. All
unaffected carriers of the FSHD-sized 4qA166 allele in both fam-
ilies have reached the age range at which the disease usually
becomes manifest.
DNA Isolation
DNA was isolated from peripheral-blood lymphocytes (PBLs).
PBLs were embedded in agarose plugs (InCert agarose [FMC]) at
a concentration of 5#105 cells per plug and were treated with
600 mg/ml pronase and 1% Sarkosyl for 40–48 h at 37C. Next,
plugs were washed in Tris-EDTA (TE)4 and were stored in 0.5 M
EDTA at 4C. Before they were used, plugs were successively equil-
ibrated in TE4 and the appropriate restriction-enzyme buffer.
Repeat Length and Distal Variation
For D4Z4 array sizing, DNA samples were double digested with
EcoRI and HindIII or EcoRI and BlnI or with XapI only. To deter-
mine the distal A/B variation at 4qter, DNA was digested with
HindIII.18 All digestions were performed according to the man-
ufacturer’s instructions. EcoRI, HindIII, and XapI were purchased
from MBI Fermentas, and BlnI was purchased from GE Healthcare.
DNA was separated in a 22-h run on a 0.85% agarose gel (MP
agarose [Roche]) by pulsed-field gel electrophoresis (PFGE) at 8.5
V/cm in four identical cycles, with a switch time increasing lin-
early from 1 s at the start to 20 s at the end of each cycle. The
run was performed in 0.5#Tris/borate/EDTA supplemented with
150 ng/ml ethidium bromide at 23C.
Restriction Analysis of Proximal D4Z4 Unit
The D4Z4 SNP in the first (proximal) unit of the D4Z4 repeat
(AF117653:g.6045GrC) was analyzed in genomic DNA samples
by a double digestion with PvuII and BlnI. PvuII and BlnI were
purchased from GE Healthcare. The Southern-blot analysis of
the PvuII polymorphism with probe p13E-11 (D4F104S1)2 reveals
chromosome 4–derived fragments of 2,849 bp (C variant, PvuII)
or 4,559 bp (G variant, PvuII) in size, depending on the presence
or absence of the PvuII restriction site, whereas chromosome 10–
derived fragments are 2,464 bp because of the presence of a BlnI
restriction site.4
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Figure 1. A, Schematic representation of the D4Z4 repeat on
chromosomes 4q35 and 10q26 with the localization of the four
polymorphic markers used in this study. The SSLP marker is lo-
calized 3.5 kb proximal to D4Z4. The D4Z4 SNP, the D4Z4-repeat
size variation, and the distal A/B variation have been described
elsewhere.4,18 The 475-bp D4F104S1 sequence is localized imme-
diately proximal to D4Z4. B, Overview of the total number of control
and patient alleles that were tested for these polymorphisms.
Blotting and Hybridization
After digestion and gel electrophoresis, DNA was transferred to
a Hybond XL membrane (GE Healthcare) by Southern blotting.
Hybridization was performed in a buffer containing 0.125 M
Na2HPO4 (pH 7.2), 10% PEG6000, 0.25 M NaCl, 1 mM EDTA, and
7% SDS for 16–24 h at 65C.
Membranes for D4Z4 sizing were hybridized with probe p13E-
11 and were washed in 2# saline sodium citrate (SSC) and 0.1%
SDS. For A/B typing, membranes were sequentially hybridized
with probes 4qA or 4qB and were washed in either 1#SSC and
0.1% SDS (4qA) or 0.3#SSC and 0.1% SDS (4qB). The linear gels
for the PvuII polymorphisms in the most proximal D4Z4 unit
were hybridized with p13E-11 and were washed in 0.3#SSC and
0.1% SDS. All membranes were exposed for 16–48 h to phos-
phorimager screens and were analyzed with the Image Quant
software program (Molecular Dynamics).
Genotyping of the SSLP
The SSLP proximal to D4Z4 is localized between positions 1532
and 1694 of AF117653 and was studied by PCR with the use of
forward primer 5′-GGTGGAGTTCTGGTTTCAGC-3′ and reverse
primer 5′-CCTGTGCTTCAGAGGCATTTG-3′. For fragment anal-
ysis, the forward primer was labeled with HEX. SSLP fragments
were amplified using standard PCR methods, and size differences
were determined with the use of an ABI Prism 3100 Genetic An-
alyzer. Primers were designed using Primer3 software.
Determination of SSLP and D4F104S1 Sequences
The majority of the SSLP and D4F104S1 sequences were deter-
mined in the somatic cell hybrids and DNA clones described
above. For the analysis of the SSLP sequence in other 4qA161
and 4qB163 alleles, so-called monosomic individuals were ana-
lyzed. Monosomic individuals carry a translocated chromosome
10–derived D4Z4 repeat on one of their chromosomes 4.20 Se-
quence analysis of the monoallelic DNA sources showed that 10q-
derived alleles include an 8-nt insertion in their SSLP sequence
that is not present on 4qA161 and 4qB163 alleles. Consequently,
DNA digestion in monosomic individuals who carry the 4qA161
or 4qB163 haplotype on their normal chromosome 4, with use
of the 8-nt insertion-specific restriction enzyme FspBI, allows a
discriminative PCR covering each of these SSLP sequences.
The D4Z4 SNP leading to a polymorphic PvuII site within D4Z4
was used for the analysis of the SSLP and D4F104S1 sequence of
4qB162, 4qB166, and 4qB168 alleles. This polymorphic PvuII site
is present in alleles encompassing the G variant (4qB162, 4qB164,
4qB166, and 4qB168 alleles) and is virtually absent in all other
haplotypes. PvuII digestion of the alleles carrying the G variant
results in a 4,764-bp fragment containing this SSLP sequence,
whereas alleles belonging to other haplotypes give rise to restric-
tion fragments of 6,475 bp in size. Therefore, PvuII-digested chro-
mosomal DNA from individuals who carry a single allele with
the G variant allows the isolation of a gel slice of ∼4,764 bp
containing the SSLP and D4F104S1 region. Purified DNA from
this gel slice was used in a PCR specific to both regions.
Finally, the SSLP and D4F104S1 sequences of 4qA166 alleles
and the D4F104S1 sequences of additional 4qA161 alleles were
derived from gel slices containing EcoRI-digested chromosomal
DNA fragments of appropriate size after PFGE analysis. The po-
sition of the D4Z4 repeat in the gel was determined using an
appropriate molecular size standard (MidRange I PFG Marker
[New England Biolabs]), after which the fragments were sliced
out of the gel and the DNA was isolated.
For both PvuII and EcoRI sliced agarose fragments, the DNA was
extracted with a gel extraction kit (Machery Nagel Gel Extraction
NS Extract II) that allows the extraction of DNA fragments !50
kb. The SSLP sequence was determined with the primers disclosed
in the “Genotyping of the SSLP” section. The D4F104S1 sequence
was analyzed using forward primer 5′-CCCAGTTACTGTTCTG-
GGTGA-3′ and reverse primer 5′-GAAAGCCCCCTGTGGGAG-3′.
Primers were designed using Primer3 software.
Statistical Analyses
Differences among major haplogroups with respect to the D4Z4
SNP were tested by means of a nonparametric Wilcoxon-Mann-
Whitney test with Monte-Carlo simulation (10,000 randomiza-
tions). To obtain a global estimate of D4Z4-repeat number dif-
ferences among the haplotypes, we used a Kruskall-Wallis test
with Monte-Carlo simulation (10,000 randomizations). Both tests
were performed using StatXact 4 from Cytel Software. Descriptive
statistics (mean, median, and counts) were obtained using the
descriptive data–analysis tool included in Microsoft Excel.
Results
Allelic Subdivision of 4q Subtelomere
We demonstrated elsewhere that mitotic D4Z4 rearrange-
ments occur at a much higher frequency intrachromo-
somally than interchromosomally.4 Furthermore, the ap-
parent suppression of recombination between 4qA and
4qB type alleles was confirmed by the different distribu-
tion of a SNP within the proximal D4Z4-repeat unit on
4qA and 4qB chromosome ends.4 In this study, the se-
quence variation within the FSHD locus was further an-
alyzed using four different polymorphisms (fig. 1A). Prox-
imal to D4Z4, we identified a novel, relatively stable SSLP
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Figure 2. Examples of D4Z4 genotyping, including the three polymorphic markers in control individual (1) and FSHD-affected patient
(2). A, D4Z4 sizing and A/B typing after PFGE and Southern blotting. For D4Z4 sizing, DNA was digested with restriction enzymes EcoRI
and HindIII (lane E), EcoRI and BlnI (lane B), or XapI (lane X), and the blotted DNA was hybridized with probe p13E-11 located
immediately proximal to D4Z4 (left panel). The four fragments present in lane E represent two 4q- and two 10q-derived repeat arrays
with different repeat sizes. The 4q or 10q origin of the D4Z4 repeats can be determined by digestions with BlnI or XapI, which fragmentize
10q- or 4q-derived repeat arrays, respectively. Consequently, individual 1 carries 4q D4Z4 repeats of 40 kb and 55 kb and 10q repeats
of 95 kb and 130 kb, whereas individual 2 carries 4q alleles of 35 kb and 165 kb and 10q repeats of 50 kb and 65 kb. For A/B typing,
DNA was digested with HindIII (lane H) and was hybridized serially with probes 4qA and 4qB, located immediately distal to D4Z4 (right
panel). Both 4q alleles (40 kb and 55 kb) in individual 1 carry the B variant, and both 4q alleles (35 kb and 165 kb) in individual 2
carry the A variant. As was shown elsewhere, 10q alleles almost always carry the A variant.18 The molecular weight marker (M) in
kilobases is shown in the middle. Cross-hybridizing Y-chromosome–derived fragments with probe p13E-11 in individual 2 (male) are
indicated with “Y.” Non-4q and -10q cross-hybridizing fragments with probes 4qA and 4qB are marked with an asterisk (*). B, Analysis
of the G/C SNP within D4Z4 (for description, see the work of Lemmers et al.4). Double digestion of genomic DNA with PvuII and BlnI
(PB) reveals 10q fragments of 2,464 bp upon hybridization with p13E-11. 4q alleles reveal fragments of either 4,559 bp or 2,849 bp,
depending on the presence (C variant) or absence (G variant) of the PvuII restriction site in D4Z4, respectively. One 4qB allele in
individual 1 contains the C variant, whereas all other 4q alleles in both individuals carry the G variant. C, Example of the fragment run
of the SSLP sequence. Altogether, this analysis demonstrates that individual 1 carries a 4qB161 and a 4qB163 allele next to the two
10qA166 alleles and that individual 2 carries two 4qA161 alleles and two 10qA166 alleles.
that was shown to be moderately polymorphic on 4q and
10q alleles. In the D4Z4 repeat, the D4Z4 SNP within the
most proximal unit was analyzed. Furthermore, the length
of the repeat array was determined in addition to the distal
A/B variation. All these analyses were done using Southern
blotting (for D4Z4 length, A/B variation, and D4Z4 SNP)
or PCR (for SSLP variation). In total, 222 independent con-
trol individuals and 86 independent patients with FSHD
were analyzed for the D4Z4-repeat size, the A/B polymor-
phism, and the SSLP variation. Of these individuals, 151
controls and 53 patients with FSHD were also analyzed
for the D4Z4 SNP (fig. 1B). An example of the genotyping
of 4qter and 10qter alleles in two unrelated individuals is
depicted in figure 2. Figure 2A shows the analysis of the
D4Z4 size variation and determination of the A/B poly-
morphism by PFGE. Figure 2B shows Southern-blot anal-
ysis of the D4Z4 SNP, and figure 2C shows the results of
the SSLP analysis by PCR in the same individuals.
The size of the SSLP sequence was next established in
six independent 10q sequences from GenBank (accession
numbers AL845259, AY028079, BX649463, BX294170,
BX005259, and AL954635) and three monoallelic DNA
sources (M&M), and they were found to be 165 bp without
sequence variation (fig. 3). Further analysis showed that
the peak at 166 bp in the SSLP fragment run represents
the 165-bp 10q fragment and that the running pattern is
disturbed by a specific 8-nt sequence within this SSLP (see
below).
After analysis of all alleles with the above-described
markers, all alleles from the control individuals were cat-
egorized and counted. An overview of the different 4q and
10q haplotypes is depicted in figure 4B. On the basis of
the proximal SSLP, 4qA alleles ( ) are able to benp 200
subdivided into three haplotypes (4qA161, 4qA163, and
4qA166). Of these haplotypes, 4qA161 is the most prev-
alent (86%). All but one 4qA allele analyzed for the D4Z4
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Figure 3. Haplotype analyses of individual 4q and 10q DNA sources, of which the last six 10q sequences are obtained from GenBank.
The identity of the DNA source is shown in the first column. The haplotype and the SSLP sequence are listed in columns 2 and 3,
whereas the D4Z4 SNP is shown in column 4. The last two columns display the D4Z4-repeat length (in kb) and the distal variation.
SNP (127 of 128) carry the G variant of the D4Z4 SNP. 4qB
alleles ( ) are more polymorphic for the proximalnp 244
SSLP and are able to be subdivided into six haplotypes:
4qB161 (2%), 4qB162 (5%), 4qB163 (68%), 4qB164 (1%),
4qB166 (3%), and 4qB168 (21%). The 4qB163 haplotype
represents the most common haplotype, and the majority
of the alleles within this haplotype (107 of 108) have the
G variant of the D4Z4 SNP. In the small number of 4qB161
alleles ( ), we found only the G variant of the D4Z4np 4
SNP. By contrast, almost all alleles belonging to other 4qB
haplotypes (61 of 62) carry the C variant of the D4Z4 SNP.
There is a significant difference in distribution of the D4Z4
SNP between 4qA and 4qB haplotypes ( ) and be-P ! .0001
tween 4qB163 and 4qB162, 4qB166, and 4qB168 haplo-
types ( ). 10q alleles seemed more homogeneousP ! .0001
than 4q alleles and were subdivided into the haplotypes
10qA166 (96%) and 10qA164 (4%). All GenBank 10qA166
sequences mentioned above and monoallelic 10qA166
sources show the G variant in D4Z4 (fig. 3).
The almost invariable presence of the 166-bp SSLP on
chromosome 10 was concluded from segregation analysis
in a subset of families with FSHD ( segregations)np 52
and from the observation that, on SSLP analysis, individ-
uals homozygous for 4qA ( ) invariably presentednp 41
with a peak of double intensity at 166 bp (10qA166), in
addition to peaks of single or double intensity at 161 bp
(4qA161) or 163 bp (4qA163) or increased intensity of the
peak at 166 bp (4qA166).
FSHD Alleles and Individual 4q Sources
Since contractions of the D4Z4 repeat on 4qA alleles are
associated with FSHD, carriers of a pathogenic D4Z4 repeat
were also studied for these four polymorphisms. In total,
86 independent FSHD alleles were analyzed, and all were
shown to belong to the 4qA161 haplotype, on the basis
of the SSLP and the distal A/B variation. Of these alleles,
53 were analyzed for the D4Z4 SNP, and all carried the G
variant.
In addition, eight monosomic 4q sources were com-
pletely genotyped (fig. 3). Five 4qA sources that represent
pathogenic alleles from patients with FSHD display the
characteristics of the 4qA161 haplotype. Furthermore, three
monochromosomal rodent somatic cell hybrids that carry
4qB alleles were analyzed and were shown to belong to
the 4qB163 and 4qB168 haplotypes.
Nonpathogenic 4q Haplotypes
It was surprising that all 86 FSHD alleles analyzed belong
to the 4qA161 haplotype (fig. 4C). No FSHD alleles that
belong to the 4qA166 haplotype were found, even though
they represent 11% of the total 4qA alleles in control in-
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Figure 4. Overview of the different haplotypes that were defined after complete genotyping of 4qA, 4qB, and 10q alleles. A, All D4Z4-
repeat units on 10q alleles encompass the BlnI restriction site (B), which is absent in D4Z4 in all 4q alleles. Likewise, all D4Z4-repeat
units on 4q alleles encompass the XapI restriction site (X) that is absent in D4Z4-repeat units on 10q alleles, except for D4Z4 repeats
in the 4qA166 haplotype, which lack the XapI restriction site in their most proximal D4Z4 unit (indicated with an asterisk [*]). B,
Genotyping of 4q and 10q alleles in control individuals. The first column lists the different haplotypes that have been identified, and
the second shows the sequence of the SSLP in each haplotype (M p A or C). Those haplotypes for which we could not obtain SSLP
sequence information are indicated by “NA” (not analyzed). The third and fifth columns represent, respectively, the number of alleles
found in each haplotype (SSLP n) and the prevalence (%) of each haplotype among 4qA, 4qB, and 10q alleles. The distribution of the
G and C variants in the D4Z4 SNP is shown in the fourth column (D4Z4 SNP (G/C)). In total, 200 4qA alleles were genotyped, and, on
the basis of SSLP length, they were subdivided into three haplotypes: 4qA161, 4qA163, and 4qA166. 4qB alleles ( ) werenp 244
subdivided into six haplotypes, designated as 4qB161, 4qB162, 4qB163, 4qB164, 4qB166, and 4qB168, and 10q alleles into haplotypes
10qA166 and 10qA164. There is a significant difference in D4Z4 SNP distribution between 4qA and 4qB haplotypes ( ) andP ! .0001
between 4qB163 and 4qB162, 4qB166, and 4qB168 haplotypes ( ). C, Genotyping of alleles with an FSHD-sized D4Z4 repeat.P ! .0001
Without exception, all FSHD alleles belong to the 4qA161 haplotype. All alleles with an FSHD-sized repeat that belong to the 4qA166
or 4qB163 haplotypes are nonpathogenic.
dividuals. However, we identified two patients from in-
dependent families with FSHD in whom we found evi-
dence of the nonpathogenicity of D4Z4 contractions on
4qA166 alleles. Both of them carried 4qA166 alleles having
D4Z4-repeat sizes in the pathogenic range, in addition to
an FSHD-sized 4qA161 D4Z4 repeat. This latter allele we
considered to be pathogenic, on the basis of its cosegre-
gation with disease.
Family Rf10 is a 3-generation FSHD-affected family
with patients who are moderately affected (fig. 5). The pre-
vious molecular diagnosis of this family was very complex
because the 33-kb (8 D4Z4 units) 4qA allele was detected
not only in the affected family members but also in a
healthy spouse (individual II-9). Our current study reveals
that this healthy spouse carries a 33-kb 4qA166 allele,
whereas a 33-kb 4qA161 allele was detected in all patients
with FSHD in this family, indicating its causal relation to
disease. Additional genotyping of the family of individual
II-9 showed that his brother (II-11) also carries the 33-kb
4qA166 allele and is not affected with FSHD.
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Figure 5. Pedigrees of FSHD-affected families Rf10 and Rf204. The patients with FSHD in family Rf10 carry a 33-kb 4qA161 (33A161)
allele and are moderately affected. Individuals II-9 and II-11 carry a 33-kb 4qA166 (33A166) allele and do not display any clinical signs
of muscular dystrophy. In family Rf204, all patients with FSHD carry a 17-kb 4qA161 (17A161) allele and are moderately to severely
affected. Six individuals carry an FSHD-sized allele of 24 kb (24A166), which belongs to the 4qA166 haplotype, and they are not affected
(II-11, III-2, III-3, III-4, III-5, and III-6). Index cases are indicated with an arrow.
In family Rf204, a 17-kb (3 D4Z4 units) 4qA161 allele is
causing FSHD. The patients of this family are moderately
to severely affected. A second FSHD-sized allele (24 kb, 5
D4Z4 units) in this family has been reported elsewhere19
but was now shown to belong to the 4qA166 haplotype.
Although D4Z4 repeats of 24 kb on 4qA alleles would be
expected from prior information to cause FSHD, six in-
dividuals (II-11, III-2, III-3, III-4, III-5, and III-6) who carry
this allele have no clinical signs of muscular dystrophy.
Only one individual (II-7) who carries this allele developed
FSHD, but she also carries the 17-kb pathogenic 4qA161
allele.
In addition to these nonpathogenic D4Z4 contractions
on 4qA166 alleles, we further substantiated our previous
observation that contractions on 4qB alleles do not cause
FSHD.21 At present, we identified 17 FSHD-sized D4Z4 re-
peats on 4qB alleles in independent individuals. In line
with previous findings on 4 of these alleles, none of these
17 alleles were shown to be pathogenic. We determined
the haplotype of 13 of these nonpathogenic alleles and
showed that they all belong to the 4qB163 haplotype (fig.
4C).
Haplotype-Specific Sequences
To find further evidence of the accumulation of haplo-
type-specific sequence variations at 4qter, we determined
the sequence of the SSLP and a 475-bp fragment in
D4F104S1 in the different haplotypes. To this end, the
SSLP and D4S104F1 fragment were PCR amplified and
were sequenced in at least three independent sources of
the most common 4q and 10q haplotypes. As shown in
figure 6, each haplotype analyzed is defined by a unique
combination of 15 SNPs within the D4F104S1 fragment.
The SSLP was shown to consist of a number of short,
rather stable microsatellite repeats (CA and CT). In addi-
tion, the SSLP contains an A/C SNP, a G/T SNP, and a poly-
morphic insertion of 8 nt (fig. 4B). On the basis of these
results, the 10qA166 haplotype can be distinguished from
the most abundant 4q haplotypes (4qA161 and 4qB163)
by the presence of SNP variant T, a CT stretch of 7 instead
of 6 dinucleotides, and the presence of the 8-nt insertion.
On the basis of the SSLP sequence, most haplotypes can
now be distinguished from each other. Similar to the
10qA166 SSLP sequence, other alleles that carry the 8-nt
insertion (4qA166, 4qB162, 4qB166, and 4qB168) were
also shown to be 1 nt smaller on sequencing than in the
SSLP fragment run.
In retrospect, we carefully reanalyzed D4Z4 sizing by
PFGE of 4qA166 alleles with restriction enzymes EcoRI/
HindIII, EcoRI/BlnI, and XapI. In total, we analyzed 15 dif-
ferent 4qA166 alleles and observed that, as expected, all
D4Z4 units lack the BlnI restriction site within their re-
peats, as is characteristic of 4q repeats (data not shown).
Remarkably, all these alleles also lack the XapI restriction
Figure 6. Alignment of a 475-bp consensus sequence within D4F104S1 of the most common haplotypes (4qA161, 4qB163, 4qA166,
4qB168, and 10qA166). The consensus is based on the sequence of at least three independent alleles for each specific haplotype. The
highlighted nucleotides indicate the presence of haplotype-specific SNPs. Similar to the SSLP, the 4qB163 sequence is very homologous
to the pathogenic 4qA161 sequence, whereas the 4qA166 sequence is more homologous to the 10qA166 and 4qB168 sequences.
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Figure 7. A, Overview of D4Z4-repeat length distribution in the
most common haplotypes, 4qA161, 4qB163, and 10qA166. Statis-
tical analysis revealed that the D4Z4-repeat size distributions differ
significantly between these haplotypes ( ). B, Mean andP ! .0001
median of the D4Z4-repeat length and number of alleles in the
major haplotypes.
site in their first unit. This insensitivity for BlnI and XapI
in the first repeat unit of the D4Z4 repeat could not be
observed in alleles of the other 4q haplotypes. Since the
XapI restriction site is localized 2.7 kb distal to D4F104S1,
this finding suggests the presence of additional haplotype-
specific sequence variations in D4Z4 and reinforces our
interpretation of the LD extending into the D4Z4-repeat
unit.
D4Z4-Repeat Size Distribution
Finally, the D4Z4-repeat size distribution was studied in
the different haplotypes. It was shown elsewhere that both
4q and 10q alleles display a multimodal repeat size dis-
tribution.20 Because of a limited number of alleles in the
low-abundance haplotypes, the size distribution was an-
alyzed only for the most common types on chromosomes
4 and 10. This analysis showed that these haplotypes show
a significantly different distribution ( ) of D4Z4-P ! .0001
repeat sizes (fig. 7A). In addition, the mean and median
of the different D4Z4 alleles were calculated for these hap-
lotypes (fig. 7B). The observed sequence variations in the
SSLP and D4F104S1 sequences and the differences in the
mean and median D4Z4-repeat size and size distribution
corroborate the concept that the different haplotypes have
evolved independently of each other.
Discussion
Contractions of the macrosatellite repeat D4Z4 cause
FSHD, but the molecular mechanism underlying this my-
opathy is largely unknown. Transcription emanating from
D4Z4 has never been consistently established, which led
to different disease models in which the contraction of
D4Z4 causes a change in chromatin conformation and loss
of spatiotemporal control over gene expression in cis or
in trans.7–13 However, none of these models can compre-
hensively explain the epigenetic mechanisms underlying
FSHD.
To study the role of D4Z4 in the pathogenesis of FSHD,
allelic variants of the D4Z4 region have been analyzed.
Previously,16 D4Z4 repeats were detected on three different
chromosome ends—on two variants of chromosome 4
(4qA and 4qB) and on chromosome 10q. In addition, a
polymorphic sequence variation within D4Z4 on 4qB al-
leles suggested the existence of additional allelic D4Z4
variants.18 The aim of this study was to investigate the
allelic variation in D4Z4 alleles in relation to the 4qA spec-
ificity of FSHD. Therefore, we examined sequence varia-
tions on 4qA, 4qB, and 10q chromosomes, by analyzing
four different polymorphic markers in patients and con-
trols of European descent. The markers are localized prox-
imal to (for SSLP), within (for D4Z4 SNP and D4Z4-repeat
number variation), and distal to (for A/B) the D4Z4 repeat.
As shown in figure 4B, we were able to unequivocally
subdivide all 4qter and 10qter chromosomes in nine dif-
ferent 4q and two distinct 10q haplotypes. The presence
of rare alleles within a haplotype that carry a D4Z4 SNP
variant different from the majority of alleles indicates that
exchanges between the different haplotypes do occur but
at a very low frequency and supports the observation that
D4Z4 contractions generally occur intrachromosomally.4
Subsequently, we stratified for alleles with D4Z4-repeat
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sizes !38 kb, which usually fall into the pathogenic range
(fig. 4C).18,21 In total, 86 FSHD alleles were analyzed, and
all could be assigned to the 4qA161 haplotype. Impor-
tantly, in two independent families (Rf10 and Rf204), we
were able to show the presence of 4qA166-type FSHD-sized
D4Z4 repeats in multiple unaffected relatives, indicating
that these alleles are nonpathogenic. Finally, we identified
17 FSHD-sized D4Z4 repeats on 4qB alleles, which were
all nonpathogenic. Further genotyping of these short 4qB
alleles showed that they all belong to the 4qB163 hap-
lotype. These two findings show that D4Z4 contractions
alone are insufficient to cause disease.
Sequence comparison of the SSLP and D4F104S1 se-
quences in the different haplotypes showed the presence
of only a few consistent sequence variations between the
nonpathogenic 4qB163 and the pathogenic 4qA161 hap-
lotypes. In alleles from the nonpathogenic 4qA166 hap-
lotype, we observed the absence of the XapI restriction
site in the proximal D4Z4-repeat unit, a feature charac-
teristic of chromosome 10–derived repeat units and not
observed in other 4q haplotypes. Furthermore, 4qA166
and 10qA166 haplotypes share high sequence similarities
in their SSLP and D4F104S1 sequences, which differ con-
siderably from the sequence of the 4qA161 haplotype (figs.
4 and 6).
Previously, the nonpathogenicity of FSHD-sized D4Z4
repeats on chromosome 10 was explained by its chromo-
somal context: only the transcriptional activity of genes
on 4q, not that of genes on 10q, would be sensitive to
D4Z4-repeat contractions. Moreover, the A/B variation
distal to D4Z4 was thought to play a role in the non-
pathogenicity of short 4qB alleles. This study shows that
neither of these explanations comprehensively address-
es the unique association of FSHD with D4Z4 contrac-
tions on specific haplotypes, since 4qA166 alleles are now
shown to be nonpathogenic as well.
Apparently, because of suppression of interchromoso-
mal rearrangements, each haplotype evolves relatively in-
dependently, which allows the accumulation of haplo-
type-specific sequence variations that may underlie the
4qA161 specificity of FSHD. These sequence variations
may be important for the chromatin structure or tran-
scriptional characteristics of the 4q subtelomere and
changes thereof in FSHD and must be located close to
(distal or proximal) or within D4Z4.
Interestingly, the region immediately proximal to D4Z4
has been implicated to function as a nuclear matrix at-
tachment region (MAR) separating the D4Z4 repeat and
upstream genes in two DNA loops.22 This MAR was shown
to be weakened on one chromosome 4 in FSHD myoblasts,
suggesting the coexistence of the contracted D4Z4 repeat
and upstream genes in a single DNA loop on disease chro-
mosomes. It was postulated that these differences in loop
organization may account for the transcriptional dereg-
ulation of the upstream genes FRG1 and FRG2 in FSHD.10
Since we found haplotype-specific sequence variations in
the region coinciding with this MAR, it will be interesting
to study the functionality of the MAR in the different
haplotypes and to determine whether the MAR weakening
in contracted alleles is specific to the 4qA161 haplotype.
Alternatively, D4Z4 homologues recently have been
identified in the genomes of rodents and Afrotheria.23
The hypothetical DUX4 gene was shown to be conserved
during evolution, which might support a coding function
for D4Z4. Therefore, it is eminent to further investigate
the presence of haplotype-specific sequence variations in
DUX4 in relation to FSHD.
Altogether, our study demonstrates that the subtelomeric
region of chromosome 4q35 can be divided into nine dif-
ferent haplotypes. Our data strongly support the hypoth-
esis that interchromosomal repeat exchanges between the
different 4q haplotypes are rare, which allows each of the
haplotypes to accumulate specific sequence variations.
Only D4Z4 contractions in specific haplotypes, most no-
tably 4qA161, seem to be associated with FSHD. Therefore,
future research should be focused on identifying consis-
tent sequence variations for the different haplotypes, since
these variations may be essential to FSHD pathogenesis.
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